{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:25:38Z","timestamp":1787286338355,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This article synthesizes the major conceptual and therapeutic transformations in myopia management from the early twentieth century to the present era of designed defocus and multimodal care, examining how myopia evolved from a simple refractive inconvenience into a measurable disorder of ocular growth and a global public-health concern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This article presents a conceptual synthesis of the historical evolution of myopia management using PubMed and Scopus (through 14 February 2026), supplemented by selected historical ophthalmology texts. The search included combinations of the terms \u201cmyopia\u201d, \u201caxial elongation\u201d, \u201catropine\u201d, \u201corthokeratology\u201d, \u201cdefocus lenses\u201d, \u201cmyopia control\u201d, and \u201cepidemiology\u201d. Priority was given to landmark trials, historical publications, and studies representing conceptual or methodological advances. Evidence was selected based on methodological rigor and historical or conceptual impact. The identified literature was synthesized into six interpretative phases reflecting progressive shifts in theoretical models, outcome measurement, and clinical objectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six major conceptual phases were identified, marking a transition from optical compensation (1900\u20131950) to early therapeutic experimentation (1950\u20131980), biometric and experimental consolidation (1980\u20132000), conceptual paradigm shift (2000\u20132010), evidence-based myopia control (2010\u20132020), and the current era of designed defocus and multimodal strategies (2020\u2013present).<\/jats:p>\n                    <jats:p>The introduction of axial length as a structural endpoint, together with large-scale epidemiology and randomized controlled trials, reframed myopia as a dynamic growth disorder. Pharmacologic modulation with low-dose atropine, corneal reshaping techniques, multifocal and dual-focus contact lenses, and defocus-incorporated spectacle designs have consistently demonstrated reductions in axial elongation.<\/jats:p>\n                    <jats:p>Even modest annual slowing of eye growth may translate into substantial reductions in lifetime risk of myopia-related complications. While interventions are primarily applied in childhood, their ultimate objective is the reduction of adult myopia-related morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Over the past century, myopia management has shifted from an optical correction to a careful control of axial elongation. The convergence of structural measurement, experimental evidence, and rigorous clinical trials has redefined therapeutic goals, aligning individual patient care with population-level risk reduction.<\/jats:p>\n                    <jats:p>This evolution highlights current preventive and personalized strategies and predicts further advances toward anticipatory modulation of ocular growth.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00417-026-07464-1","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:07:20Z","timestamp":1787285240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The conceptual evolution of myopia management: from refractive correction to axial-length\u2013based risk modulation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-2977","authenticated-orcid":false,"given":"Irene","family":"Schiavetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"7464_CR1","unstructured":"Aristotle (1936) Problems. Book XXXI. Translated by W. S. Hett. Harvard University Press"},{"key":"7464_CR2","volume-title":"The history of ophthalmology","author":"J Hirschberg","year":"1982","unstructured":"Hirschberg J (1982) The history of ophthalmology. JP Wayenborgh, Bonn, Germany"},{"key":"7464_CR3","volume-title":"A Greek-English lexicon","author":"HG Liddell","year":"1940","unstructured":"Liddell HG, Scott R (1940) A Greek-English lexicon. Clarendon Press, Oxford, England"},{"key":"7464_CR4","volume-title":"The myopias: basic science and clinical management","author":"BJ Curtin","year":"1985","unstructured":"Curtin BJ (1985) The myopias: basic science and clinical management. Harper & Row, Philadelphia, PA"},{"issue":"9827","key":"7464_CR5","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","volume":"379","author":"IG Morgan","year":"2012","unstructured":"Morgan IG, Ohno-Matsui K, Saw SM (2012) Myopia. Lancet 379(9827):1739\u20131748. https:\/\/doi.org\/10.1016\/S0140-6736(12)60272-4","journal-title":"Lancet"},{"key":"7464_CR6","volume-title":"Ad Vitellionem Paralipomena, Quibus Astronomiae Pars Optica Traditur\u2026 De Modo Visionis, et Humorum Oculi Usu, Contra Opticos et Anatomicos","author":"J Kepler","year":"1604","unstructured":"Kepler J (1604) Ad Vitellionem Paralipomena, Quibus Astronomiae Pars Optica Traditur\u2026 De Modo Visionis, et Humorum Oculi Usu, Contra Opticos et Anatomicos. C. Marnius & Heirs of J. Aubrius, Frankfurt"},{"key":"7464_CR7","unstructured":"Proust M (1929) In Search of Lost Time. Vol 5. The Captive. Translated by Moncrieff CK. London: Chatto & Windus"},{"key":"7464_CR8","volume-title":"System of Ophthalmology","author":"S Duke-Elder","year":"1970","unstructured":"Duke-Elder S (1970) Ophthalmic Optics and Refraction. System of Ophthalmology, vol Vol 5. Henry Kimpton"},{"issue":"6","key":"7464_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2012.06.004","volume":"31","author":"DI Flitcroft","year":"2012","unstructured":"Flitcroft DI (2012) The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res 31(6):622\u2013660. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.06.004","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"7464_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuron.2004.08.008","volume":"43","author":"J Wallman","year":"2004","unstructured":"Wallman J, Winawer J (2004) Homeostasis of eye growth and the question of myopia. Neuron 43(4):447\u2013468. https:\/\/doi.org\/10.1016\/j.neuron.2004.08.008","journal-title":"Neuron"},{"key":"7464_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","volume":"62","author":"IG Morgan","year":"2018","unstructured":"Morgan IG, French AN, Ashby RS et al (2018) The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res 62:134\u2013149. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.09.004","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"7464_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA et al (2016) Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 123(5):1036\u20131042. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006","journal-title":"Ophthalmology"},{"issue":"7543","key":"7464_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/519276a","volume":"519","author":"E Dolgin","year":"2015","unstructured":"Dolgin E (2015) The myopia boom. Nature 519(7543):276\u2013278. https:\/\/doi.org\/10.1038\/519276a","journal-title":"Nature"},{"key":"7464_CR14","doi-asserted-by":"publisher","unstructured":"Smith EL 3rd (2013) Optical treatment strategies to slow myopia progression: effects of the visual extent of the optical treatment zone. Exp Eye Res 114:77\u201388. https:\/\/doi.org\/10.1016\/j.exer.2012.11.019","DOI":"10.1016\/j.exer.2012.11.019"},{"issue":"5","key":"7464_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/bjo.85.5.521","volume":"85","author":"B Seet","year":"2001","unstructured":"Seet B, Wong TY, Tan DT et al (2001) Myopia in Singapore: taking a public health approach. Br J Ophthalmol 85(5):521\u2013526. https:\/\/doi.org\/10.1136\/bjo.85.5.521","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"7464_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2004.06.004","volume":"24","author":"I Morgan","year":"2005","unstructured":"Morgan I, Rose K (2005) How genetic is school myopia? Prog Retin Eye Res 24(1):1\u201338. https:\/\/doi.org\/10.1016\/j.preteyeres.2004.06.004","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"7464_CR17","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1167\/iovs.05-1081","volume":"47","author":"SM Saw","year":"2006","unstructured":"Saw SM, Shankar A, Tan SB et al (2006) A cohort study of incident myopia in Singaporean children. Invest Ophthalmol Vis Sci 47(5):1839\u20131844. https:\/\/doi.org\/10.1167\/iovs.05-1081","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"7464_CR18","first-page":"849","volume":"123","author":"JWL Tideman","year":"2016","unstructured":"Tideman JWL et al (2016) Axial length and risk of myopia-related ocular pathology. Ophthalmology 123(4):849\u2013857","journal-title":"Ophthalmology"},{"issue":"3","key":"7464_CR19","doi-asserted-by":"publisher","first-page":"M106","DOI":"10.1167\/iovs.18-25958","volume":"60","author":"CF Wildsoet","year":"2019","unstructured":"Wildsoet CF, Chia A, Cho P et al (2019) IMI - Interventions Myopia Institute: Interventions for Controlling Myopia Onset and Progression Report. Invest Ophthalmol Vis Sci 60(3):M106\u2013M131. https:\/\/doi.org\/10.1167\/iovs.18-25958","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"7464_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","volume":"96","author":"P Chamberlain","year":"2019","unstructured":"Chamberlain P et al (2019) A 3-year randomized clinical trial of MiSight contact lenses for myopia control. Optom Vis Sci 96(8):556\u2013567","journal-title":"Optom Vis Sci"},{"issue":"3","key":"7464_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY et al (2020) Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol 104(3):363\u2013368. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"7464_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.62.5.5","volume":"62","author":"JB Jonas","year":"2021","unstructured":"Jonas JB et al (2021) IMI \u2013 Pathologic Myopia. Invest Ophthalmol Vis Sci 62(5):5","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"7464_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q et al (2016) Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology 123(4):697\u2013708","journal-title":"Ophthalmology"},{"issue":"8","key":"7464_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1136\/bjophthalmol-2017-311625","volume":"102","author":"PTVM de Jong","year":"2018","unstructured":"de Jong PTVM (2018) Myopia: its historical contexts. Br J Ophthalmol 102(8):1021\u20131027. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311625","journal-title":"Br J Ophthalmol"},{"key":"7464_CR25","first-page":"1194","volume-title":"Textbook of Ophthalmology. Volume VI: Injuries","year":"1954","unstructured":"Duke-Elder S (ed) (1954) Textbook of Ophthalmology. Volume VI: Injuries. C. V. Mosby Company, St. Louis, MO, p 1194"},{"key":"7464_CR26","volume-title":"Duke-Elder\u2019s Practice of Refraction","author":"S Duke-Elder","year":"1978","unstructured":"Duke-Elder S (1978) Duke-Elder\u2019s Practice of Refraction, 9th ed. Churchill Livingstone\/Longman, Edinburgh, Scotland & New York, NY","edition":"9th ed"},{"issue":"3","key":"7464_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1444-0938.2006.00044.x","volume":"89","author":"HA Swarbrick","year":"2006","unstructured":"Swarbrick HA (2006) Orthokeratology review and update. Clin Exp Optom 89(3):124\u2013143. https:\/\/doi.org\/10.1111\/j.1444-0938.2006.00044.x","journal-title":"Clin Exp Optom"},{"issue":"1","key":"7464_CR28","doi-asserted-by":"publisher","first-page":"000330","DOI":"10.23880\/oajo-16000330","volume":"10","author":"J Lallu","year":"2025","unstructured":"Lallu J, Wood J (2025) Orthokeratology-A Historical Summary and Update. Open Access J Ophthalmol 10(1):000330. https:\/\/doi.org\/10.23880\/oajo-16000330","journal-title":"Open Access J Ophthalmol"},{"issue":"9240","key":"7464_CR29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/S0140-6736(00)02864-6","volume":"356","author":"DA Goss","year":"2000","unstructured":"Goss DA (2000) Nearwork and myopia. Lancet 356(9240):1456\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(00)02864-6","journal-title":"Lancet"},{"issue":"8","key":"7464_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1080\/08164622.2025.2468900","volume":"108","author":"H Niyazmand","year":"2025","unstructured":"Niyazmand H, Alam K, Charng J et al (2025) The effect of near work on the anterior eye and associations with myopia: a narrative review. Clin Exp Optom 108(8):909\u2013922. https:\/\/doi.org\/10.1080\/08164622.2025.2468900","journal-title":"Clin Exp Optom"},{"issue":"5","key":"7464_CR31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s0161-6420(79)35455-0","volume":"86","author":"RH Bedrossian","year":"1979","unstructured":"Bedrossian RH (1979) The effect of atropine on myopia. Ophthalmology 86(5):713\u2013719. https:\/\/doi.org\/10.1016\/s0161-6420(79)35455-0","journal-title":"Ophthalmology"},{"key":"7464_CR32","first-page":"200","volume":"6","author":"GN Jessen","year":"1962","unstructured":"Jessen GN (1962) Orthofocus techniques. Contacto 6:200\u2013204","journal-title":"Contacto"},{"issue":"2","key":"7464_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1475-1313.1998.00342.x","volume":"18","author":"T Dave","year":"1998","unstructured":"Dave T, Ruston D (1998) Current trends in modern orthokeratology. Ophthalmic Physiol Opt 18(2):224\u2013233","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"7464_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clae.2021.02.003","volume":"44","author":"SJ Vincent","year":"2021","unstructured":"Vincent SJ, Cho P, Chan KY et al (2021) CLEAR \u2013 Orthokeratology. Cont Lens Anterior Eye 44(2):240\u2013269. https:\/\/doi.org\/10.1016\/j.clae.2021.02.003","journal-title":"Cont Lens Anterior Eye"},{"key":"7464_CR35","unstructured":"Jensen H (1991) Myopia progression in young school children. A prospective study of myopia progression and the effect of a trial with bifocal lenses and beta blocker eye drops. Acta Ophthalmol Suppl (1985) (200):1\u201379"},{"issue":"2","key":"7464_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0886-3350(13)80917-0","volume":"18","author":"T Olsen","year":"1992","unstructured":"Olsen T (1992) Sources of error in intraocular lens power calculation. J Cataract Refract Surg 18(2):125\u2013129. https:\/\/doi.org\/10.1016\/s0886-3350(13)80917-0","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"7464_CR37","first-page":"616","volume":"32","author":"CK Hitzenberger","year":"1991","unstructured":"Hitzenberger CK (1991) Optical measurement of the axial eye length by laser Doppler interferometry. Invest Ophthalmol Vis Sci 32(3):616\u2013624","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"7464_CR38","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0042-6989(94)00233-c","volume":"35","author":"C Wildsoet","year":"1995","unstructured":"Wildsoet C, Wallman J (1995) Choroidal and scleral mechanisms of compensation for spectacle lenses in chicks. Vis Res 35(9):1175\u20131194. https:\/\/doi.org\/10.1016\/0042-6989(94)00233-c","journal-title":"Vis Res"},{"key":"7464_CR39","doi-asserted-by":"publisher","unstructured":"Smith EL 3rd, Hung LF, Harwerth RS (1994) Effects of optically induced blur on the refractive status of young monkeys. Vis Res 34(3):293\u2013301. https:\/\/doi.org\/10.1016\/0042-6989(94)90088-4","DOI":"10.1016\/0042-6989(94)90088-4"},{"issue":"5","key":"7464_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/lsm.1900100511","volume":"10","author":"IG Pallikaris","year":"1990","unstructured":"Pallikaris IG, Papatzanaki ME, Stathi EZ, Frenschock O, Georgiadis A (1990) Laser in situ keratomileusis. Lasers Surg Med 10(5):463\u2013468. https:\/\/doi.org\/10.1002\/lsm.1900100511","journal-title":"Lasers Surg Med"},{"issue":"2","key":"7464_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0039-6257(95)80001-8","volume":"40","author":"T Seiler","year":"1995","unstructured":"Seiler T, McDonnell PJ (1995) Excimer laser photorefractive keratectomy. Surv Ophthalmol 40(2):89\u2013118. https:\/\/doi.org\/10.1016\/s0039-6257(95)80001-8","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"7464_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/jop.1999.15.85","volume":"15","author":"YF Shih","year":"1999","unstructured":"Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT (1999) Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 15(1):85\u201390. https:\/\/doi.org\/10.1089\/jop.1999.15.85","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"7464_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0892-8967(97)00055-2","volume":"24","author":"J Mountford","year":"1997","unstructured":"Mountford J (1997) An analysis of the changes in corneal shape and refractive error induced by accelerated orthokeratology. Int Contact Lens Clin 24(4):128\u2013144. https:\/\/doi.org\/10.1016\/S0892-8967(97)00055-2","journal-title":"Int Contact Lens Clin"},{"issue":"5","key":"7464_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0197-2456(01)00156-8","volume":"22","author":"L Hyman","year":"2001","unstructured":"Hyman L, Gwiazda J, Marsh-Tootle WL, Norton TT, Hussein M, COMET Group (2001) The Correction of Myopia Evaluation Trial (COMET): design and general baseline characteristics. Control Clin Trials 22(5):573\u2013592. https:\/\/doi.org\/10.1016\/s0197-2456(01)00156-8","journal-title":"Control Clin Trials"},{"issue":"3","key":"7464_CR45","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1167\/iovs.03-1051","volume":"45","author":"M He","year":"2004","unstructured":"He M, Zeng J, Liu Y, Xu J, Pokharel GP, Ellwein LB (2004) Refractive error and visual impairment in urban children in southern china. Investig Ophthalmol Vis Sci 45(3):793\u2013799. https:\/\/doi.org\/10.1167\/iovs.03-1051","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"7464_CR46","first-page":"332","volume":"43","author":"SM Saw","year":"2002","unstructured":"Saw SM, Chua WH, Hong CY et al (2002) Nearwork in early-onset myopia. Invest Ophthalmol Vis Sci 43(2):332\u2013339","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"7464_CR47","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archophthalmol.2009.303","volume":"127","author":"S Vitale","year":"2009","unstructured":"Vitale S, Sperduto RD, Ferris FL 3rd (2009) Increased prevalence of myopia in the United States between 1971\u20131972 and 1999\u20132004. Arch Ophthalmol 127(12):1632\u20131639. https:\/\/doi.org\/10.1001\/archophthalmol.2009.303","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"7464_CR48","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1167\/iovs.06-1118","volume":"48","author":"LA Jones","year":"2007","unstructured":"Jones LA, Sinnott LT, Mutti DO, Mitchell GL, Moeschberger ML, Zadnik K (2007) Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci 48(8):3524\u20133532. https:\/\/doi.org\/10.1167\/iovs.06-1118","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"7464_CR49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ophtha.2007.12.019","volume":"115","author":"KA Rose","year":"2008","unstructured":"Rose KA, Morgan IG, Ip J et al (2008) Outdoor activity reduces the prevalence of myopia in children. Ophthalmology 115(8):1279\u20131285. https:\/\/doi.org\/10.1016\/j.ophtha.2007.12.019","journal-title":"Ophthalmology"},{"issue":"4","key":"7464_CR50","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archopht.126.4.527","volume":"126","author":"KA Rose","year":"2008","unstructured":"Rose KA, Morgan IG, Smith W, Burlutsky G, Mitchell P, Saw SM (2008) Myopia, lifestyle, and schooling in students of Chinese ethnicity in Singapore and Sydney. Archives Ophthalmol (Chicago Ill : 1960) 126(4):527\u2013530. https:\/\/doi.org\/10.1001\/archopht.126.4.527","journal-title":"Archives Ophthalmol (Chicago Ill : 1960)"},{"issue":"8","key":"7464_CR51","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/bjo.2008.150979","volume":"93","author":"M Dirani","year":"2009","unstructured":"Dirani M, Tong L, Gazzard G, Zhang X, Chia A, Young TL, Rose KA, Mitchell P, Saw SM (2009) Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol 93(8):997\u20131000. https:\/\/doi.org\/10.1136\/bjo.2008.150979","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"7464_CR52","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ophtha.2012.11.009","volume":"120","author":"PC Wu","year":"2013","unstructured":"Wu PC, Tsai CL, Wu HL, Yang YH, Kuo HK (2013) Outdoor activity during class recess reduces myopia onset and progression in school children. Ophthalmology 120(5):1080\u20131085. https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.009","journal-title":"Ophthalmology"},{"issue":"11","key":"7464_CR53","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","volume":"314","author":"M He","year":"2015","unstructured":"He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, Smith W, Rose K, Morgan IG (2015) Effect of Time Spent Outdoors at School on the Development of Myopia Among Children in China: A Randomized Clinical Trial. JAMA 314(11):1142\u20131148. https:\/\/doi.org\/10.1001\/jama.2015.10803","journal-title":"JAMA"},{"issue":"1","key":"7464_CR54","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.1289\/ehp.122-A12","volume":"122","author":"T Lougheed","year":"2014","unstructured":"Lougheed T (2014) Myopia: the evidence for environmental factors. Environ Health Perspect 122(1):A12\u2013A19. https:\/\/doi.org\/10.1289\/ehp.122-A12","journal-title":"Environ Health Perspect"},{"issue":"12","key":"7464_CR55","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"WH Chua","year":"2006","unstructured":"Chua WH, Balakrishnan V, Chan YH et al (2006) Atropine for the treatment of childhood myopia. Ophthalmology 113(12):2285\u20132291. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.062","journal-title":"Ophthalmology"},{"issue":"1","key":"7464_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/02713680590907256","volume":"30","author":"P Cho","year":"2005","unstructured":"Cho P, Cheung SW, Edwards M (2005) The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res 30(1):71\u201380. https:\/\/doi.org\/10.1080\/02713680590907256","journal-title":"Curr Eye Res"},{"issue":"11","key":"7464_CR57","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1167\/iovs.08-2067","volume":"49","author":"JJ Walline","year":"2008","unstructured":"Walline JJ, Jones LA, Sinnott L et al (2008) A randomized trial of the effect of soft contact lenses on myopia progression in children. Invest Ophthalmol Vis Sci 49(11):4702\u20134706. https:\/\/doi.org\/10.1167\/iovs.08-2067","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"7464_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM et al (2019) Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology 126(1):113\u2013124. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029","journal-title":"Ophthalmology"},{"issue":"7","key":"7464_CR59","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X et al (2020) Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology 127(7):910\u2013919. https:\/\/doi.org\/10.1016\/j.ophtha.2019.12.011","journal-title":"Ophthalmology"},{"issue":"2","key":"7464_CR60","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB et al (2012) Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 119(2):347\u2013354. https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.031","journal-title":"Ophthalmology"},{"issue":"2","key":"7464_CR61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D (2016) Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology 123(2):391\u2013399. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.004","journal-title":"Ophthalmology"},{"issue":"11","key":"7464_CR62","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW (2012) Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci 53(11):7077\u20137085. https:\/\/doi.org\/10.1167\/iovs.12-10565","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7464_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32700-7","volume":"13","author":"CSY Lam","year":"2023","unstructured":"Lam CSY, Tang WC, Zhang HY et al (2023) Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Sci Rep 13:5475. https:\/\/doi.org\/10.1038\/s41598-023-32700-7","journal-title":"Sci Rep"},{"issue":"3","key":"7464_CR64","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/OPX.0000000000001873","volume":"99","author":"P Chamberlain","year":"2022","unstructured":"Chamberlain P, Arumugam B, Jones D et al (2022) Long-term effect of dual-focus contact lenses on myopia progression in children: 6-year follow-up of a randomized clinical trial. Optom Vis Sci 99(3):204\u2013212. https:\/\/doi.org\/10.1097\/OPX.0000000000001873","journal-title":"Optom Vis Sci"},{"key":"7464_CR65","doi-asserted-by":"publisher","unstructured":"Bao J, Yang A, Huang Y et al (2022a) One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br J Ophthalmol 106(8):1171\u20131176. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318367","DOI":"10.1136\/bjophthalmol-2020-318367"},{"key":"7464_CR66","doi-asserted-by":"publisher","unstructured":"Bao J, Huang Y, Li X et al (2022b) Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol 140(5):472\u2013478. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0401","DOI":"10.1001\/jamaophthalmol.2022.0401"},{"issue":"6","key":"7464_CR67","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2020.10834","volume":"324","author":"JJ Walline","year":"2020","unstructured":"Walline JJ, Walker MK, Mutti DO et al (2020) Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. JAMA 324(6):571\u2013580. https:\/\/doi.org\/10.1001\/jama.2020.10834","journal-title":"JAMA"},{"issue":"6","key":"7464_CR68","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","volume":"329","author":"JC Yam","year":"2023","unstructured":"Yam JC, Zhang XJ, Zhang Y et al (2023) Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA 329(6):472\u2013481. https:\/\/doi.org\/10.1001\/jama.2022.24162","journal-title":"JAMA"},{"key":"7464_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2025-328221","author":"A Chia","year":"2025","unstructured":"Chia A, Burkill S, Ling Y et al (2025) Effect of low-dose atropine on young premyopic and low-myopic children: atropine treatment of myopia (ATOM3) \u2013 a randomised control trial. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjo-2025-328221","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"7464_CR70","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","volume":"141","author":"MX Repka","year":"2023","unstructured":"Repka MX, Weise KK, Chandler DL et al (2023) Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. JAMA Ophthalmol 141(8):756\u2013765. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2855","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"7464_CR71","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","volume":"141","author":"K Zadnik","year":"2023","unstructured":"Zadnik K, Schulman E, Flitcroft I et al (2023) Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial. JAMA Ophthalmol 141(10):990\u2013999. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2097","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"7464_CR72","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","volume":"128","author":"R Saxena","year":"2021","unstructured":"Saxena R, Dhiman R, Gupta V et al (2021) Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial. Ophthalmology 128(9):1367\u20131369. https:\/\/doi.org\/10.1016\/j.ophtha.2021.01.026","journal-title":"Ophthalmology"},{"issue":"5","key":"7464_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051506","volume":"13","author":"SH Lee","year":"2024","unstructured":"Lee SH, Tseng BY, Wang JH, Chiu CJ (2024) Efficacy and safety of low-dose atropine on myopia prevention in premyopic children: systematic review and meta-analysis. J Clin Med 13(5):1506. https:\/\/doi.org\/10.3390\/jcm13051506","journal-title":"J Clin Med"},{"issue":"2","key":"7464_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaophthalmol.2024.5885","volume":"143","author":"DA Berntsen","year":"2025","unstructured":"Berntsen DA, Ticak A, Orr DJ et al (2025) Axial Growth and Myopia Progression After Discontinuing Soft Multifocal Contact Lens Wear. JAMA Ophthalmol 143(2):155\u2013162. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.5885","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"7464_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhu Z, Tan X et al (2022) Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial. Ophthalmology 129(5):509\u2013519. https:\/\/doi.org\/10.1016\/j.ophtha.2021.11.023","journal-title":"Ophthalmology"},{"issue":"5","key":"7464_CR76","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","volume":"62","author":"N Kinoshita","year":"2018","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kakehashi A (2018) Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Jpn J Ophthalmol 62(5):544\u2013553. https:\/\/doi.org\/10.1007\/s10384-018-0608-3","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"7464_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.62.5.6","volume":"62","author":"JB Jonas","year":"2021","unstructured":"Jonas JB, Ang M, Cho P et al (2021) IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci 62(5):6","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7464_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281816","volume":"18","author":"P Nucci","year":"2023","unstructured":"Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW (2023) A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine. PLoS One 18(2):e0281816. https:\/\/doi.org\/10.1371\/journal.pone.0281816","journal-title":"PLoS One"},{"issue":"6","key":"7464_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306050","volume":"19","author":"RKM Chun","year":"2024","unstructured":"Chun RKM, Hon Y, Law TK et al (2024) Combination effect of optical defocus and low dose atropine in myopia control: study protocol for a randomized clinical trial. PLoS One 19(6):e0306050. https:\/\/doi.org\/10.1371\/journal.pone.0306050","journal-title":"PLoS One"},{"issue":"11","key":"7464_CR80","doi-asserted-by":"publisher","first-page":"e2340986","DOI":"10.1001\/jamanetworkopen.2023.40986","volume":"6","author":"S Agyekum","year":"2023","unstructured":"Agyekum S, Chan PP, Adjei PE et al (2023) Cost-effectiveness analysis of myopia progression interventions in children. JAMA Netw Open 6(11):e2340986. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.40986","journal-title":"JAMA Netw Open"},{"issue":"6","key":"7464_CR81","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.64.6.6","volume":"64","author":"CF Wildsoet","year":"2023","unstructured":"Wildsoet CF, Chia A, Cho P et al (2023) IMI 2023 Digest: Updates and Clinical Management Guidelines for Myopia Control. Invest Ophthalmol Vis Sci 64(6):6. https:\/\/doi.org\/10.1167\/iovs.64.6.6","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7464_CR82","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bjophthalmol-2021-319306","volume":"107","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Chen Y, Tan Z, Xiong R, McGuinness MB, M\u00fcller A (2023) Interventions recommended for myopia prevention and control among children and adolescents in China: a systematic review. Br J Ophthalmol 107(2):160\u2013166. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319306","journal-title":"Br J Ophthalmol"},{"key":"7464_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-026-07246-9","author":"I Schiavetti","year":"2026","unstructured":"Schiavetti I, Villani E, Serafino M, Caputo R, Buzzonetti L, Vagge A, Nucci P, Italian study group on pediatric myopia (2026) Italian consensus on pediatric myopia: findings from a three-round modified delphi study. Graefe\u2019s archive Clin experimental Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. https:\/\/doi.org\/10.1007\/s00417-026-07246-9Advance online publication","journal-title":"Graefe\u2019s archive Clin experimental Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"issue":"7","key":"7464_CR84","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.4103\/IJO.IJO_387_23","volume":"71","author":"R Saxena","year":"2023","unstructured":"Saxena R, Dhiman R, Gupta V, Phuljhele S, Mahajan A, Rakheja V, Swaminathan M, Jethani J, Kesarwani S, Kekunnaya R, Sukhija J, Bhave S, Sharma P, Sinha R, Verma L, Sharma N (2023) Prevention and management of childhood progressive myopia: National consensus guidelines. Indian J Ophthalmol 71(7):2873\u20132881. https:\/\/doi.org\/10.4103\/IJO.IJO_387_23","journal-title":"Indian J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07464-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:07:23Z","timestamp":1787285243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07464-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":84,"alternative-id":["7464"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07464-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PN: Thea, Zeiss, Hoya, Essilor Luxottica, Fondazione One-sight, Thea Sifi, Bausch&Lomb, Alfa Intes, Alcon, Doc, Santen, Eyerising, CooperVision IS: Roche, Biogen, Hoya, Hippocrates Research, D.M.G Italia, Eyepharma, and DreamsLab.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}